HomeTLSIW • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$1.56
Year range
$0.42 - $5.00
Market cap
267.06M USD
Avg Volume
3.58K
P/E ratio
-
Dividend yield
-
In the news
Investing.com
10 hours ago
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings
6.39%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 13.20M | 59.85% |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | -0.05 | 87.48% |
EBITDA | -3.14M | 65.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 35.33M | 47.39% |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 61.31M | — |
Price to book | — | — |
Return on assets | -22.78% | — |
Return on capital | -204.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | 277.00K | -90.75% |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2009
Headquarters
Website
Employees
110
